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X-Linked Anhidrotic (Hypohidrotic) Ectodermal Dysplasia
Caused by a Novel Mutation in EDA1 Gene: 406T.G
(Leu55Arg)
To the Editor:
X-linked anhidrotic (hypohidrotic) ectodermal dysplasia (EDA;
MIM 305100) is one of the more common types of over 150
clinically distinct hereditary ectodermal dysplasias. It is characterized
by sparse hair, abnormal or missing teeth, and an inability to sweat
due to the lack of sweat glands (Freire-Maia and Pin˜eiro, 1994).
In addition, about two-thirds of carrier females can manifest some
of these signs. Although autosomal dominant and recessive forms
have been demonstrated, they appear to be very rare in relation to
the predominant X-linked form. The two first exons of the gene
responsible for this disorder, EDA1, were identified by Kere et al
(1996). The remaining seven exons have been recently published
(Monreal et al, 1998).
Here we show a novel mutation present in an EDA family. The
only affected male fulfils the diagnostic criteria of this disorder. In
addition, his 28 y old sister shows sparse hair, abnormal teeth, and
dryness of several skin areas, although to a lesser degree than the
index patient. In contrast, their mother is less severely affected: she
presented with scarcity of hair and dental problems beginning from
menopause.
The first exon of EDA1 gene was amplified from all members
of the family, as described elsewhere (Kere et al, 1996). The 686 bp
fragment obtained was digested with Msp I to allow SSCP analysis;
however, one of the expected fragments (of 255 bp) did not appear
in the patient’s sample. Instead two new fragments of 65 and
190 bp were seen, while his mother and sister showed the three
fragments (Fig 1). The patient’s amplified fragment as well as that
from the father were directly sequenced by using the ABI-PRISM
Figure 1. Detection of the 406T.G mutation by restriction analysis.
The DNA fragment of 686 bp containing the exon 1 of EDA1 gene was
obtained for each member of the family by polymerase chain reaction
amplification and subsequently digested with Msp I prior to electrophoresis.
The presence of the mutation generates a new Msp I site, so that the
normal fragment of 255 bp is cleaved in two fragments of 190 and 65 bp.
MW, molecular weight marker; lanes 2 and 4 show the fragments
corresponding to the heterozygous mutation; lane 3 shows the homozygous
mutation; lane 5 shows the normal fragments.
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dye terminator and the 373 sequencer (Applied Biosystems, Foster
City, CA). The substitution of thymidine by guanine at position
406 was detected (406T.G), which changes codon 55 from leucine
to arginine. Despite the fact that this mutation has not been
reported previously, this amino acid substitution is predicted to
disrupt the transmembrane domain, which strongly implies that
this is the disease-causing mutation in the family. Furthermore, this
mutation was excluded to be present in 50 normal unrelated
individuals.
To date, only 21 distinct pathogenic point mutations have been
reported in this gene, some of them present in more than one
family (Ferguson et al, 1998; Monreal et al, 1998). It is noteworthy
that Msp I digestion of exon 1 allows the detection of five of the
14 mutations so far observed in this exon. Furthermore, given the
high GC content of this exon (it is in a CpG island) and the higher
mutability of CpG dinucleotides, detection of new mutations
with this enzyme, which recognizes the sequence CCGG, may
be expected.
The broad clinical variability observed in the two females in the
family may be due to differences in the X-chromosome inactivation
pattern. Given that this inactivation pattern can apparently be
correlated among tissues that originate from different embryonic
germ layers (Pegoraro et al, 1997), we decided to compare the
ratio of inactivation of the chromosome bearing the mutation in
peripheral blood DNA from both carrier females. This was done
by characterization of a (CAG)n repeat of the androgen receptor,
near the EDA1 gene, after digestion with Hpa II or Rsa I, as
described elsewhere (Martı´nez et al, 1998). Interestingly, the affected
daughter showed a higher degree of activity of the disease-linked
allele, over 80%, than her barely symptomatic mother, who showed
about 60% of activity of this same allele. Obviously, these results
do not demonstrate that the pattern of X-inactivation observed in
blood cells is correlated with the disease severity in females;
however, our data are consistent with this idea and suggest that
X-inactivation should be investigated in further manifesting carriers.
If this hypothesis is true, the ratio of activity of the mutant X
chromosome might be useful in those cases where the mutation is
not found. It would complement the clinical examination of female
relatives of sporadic patients, and it would help differentiate the
X-linked from the autosomal dominant or recessive forms.
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What is the Best Way to Define the Antimelanocyte T Cell
Repertoire?
To the Editor:
Melanomas are most frequently infiltrated by activated lympho-
cytes. With the exception of rare spontaneous, immune-mediated
regressions of melanomas or in the halo nevus phenomenon,
the ongoing melanocyte-specific T cell responses are inefficient,
and malignant melanocytic tumors escape the immune control.
Thus, the understanding of the mechanisms underlying the
switch towards efficient/inefficient T cell responses is of primary
importance for the immunotherapy of melanomas. In recent
years, research has focused on the identification of the T cell
clones that infiltrate melanomas and are able to drive an efficient
response. These investigations have been carried out by using
either T cell clones expanded in vitro, or reverse transcriptase-
polymerase chain reaction (PCR) analysis of mRNA encoding
the T cell receptor (TCR)-β and -α chains isolated from
biopsies. The paper by Strohal et al (1998) in the Journal
describes such an attempt of approaching the TCR repertoire
in primary and metastatic melanomas. The authors semiquantitated
the TCR-BV and -AV usages in 12 autopsy specimens biopsied
in various organs of three melanoma patients. Only subsets of
TCR-BV and -AV families were found expanded in the different
biopsies. A limited number of CDR3 sequences was detected
in locally expanded TCR-BV/AV families, although no CDR3
sequence was shared by all metastatic sites of a patient. The
authors claimed that site-specific oligoclonal expansions occurred
in the patients, a finding possibly indicative either of the
recognition of different antigens due to tumor progression, or
of the local selection of different T cell clones nevertheless
recognizing the same molecular target.
The authors do not quote some important papers in the field,
however, nor do they discuss the issue that their PCR-based
technology may not have been sensitive enough to detect
nominal, antigen-driven T cell responses: in an earlier study on
the T cell repertoire in melanomas, it was shown that the
expansion of a T cell population bearing a particular TCR-β
chain may not result in an increase of a BV usage detectable
either by blot hybridization or by FACS analysis (Puisieux et al,
1994). Thus the latter techniques do not generate an accurate
picture of antigen-driven T cell responses. These limitations
explain why alternative techniques have been designed to describe
the T cell repertoire in tumor-infiltrating lymphocytes (TIL)
and in various other pathologic conditions (Pannetier et al,
1998). In the ‘‘immunoscope’’ technique developed in our
laboratory, the BV-BC amplification products are subjected to
primer extension reactions primed using either an internal BC-
specific primer, or each of the 13 fluorescently labelled BJ-
specific primers. The ‘‘run-off’’ DNA encompasses the CDR3
region of the β chain of the TCR, a region that recognizes
the antigenic peptides bound to MHC molecules. Run-off
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products are analyzed in an automated DNA sequencer in order
to determine the length spectrum of the CDR3 regions as well
as the intensity of fluorescence of each peak. The distribution
of the intensity of fluorescence as a function of the CDR3
length yields a Gaussian pattern in complex T cell populations
like BL, whereas antigen-driven responses yield pre-eminent
peaks, which distorts the Gaussian distribution. This procedure
generates a kind of snapshot of the T cells present in TIL. The
immunoscope technique, which generates up to 2000 independent
signals out of as few as 10,000 T cells, is semiquantitative.
Moreover, the cDNA peaks of interest can be isolated and
sequenced. This approach defining the T cell expansions of
interest has been used in a variety of pathologic conditions
(Musette et al, 1996; Bachelez et al, 1998; David-Ameline et al,
1996; Faure et al, 1998).
Several studies on T cells infiltrating melanocytic tumors have
been conducted using the immunoscope approach. The complex
behavior of the T cells infiltrating melanomas has been studied
by Puisieux et al (1994) and T cell clones undergoing expansion
were characterized, some of which were found infiltrating all
tumor sites of the patients, a finding conflicting with the
conclusion reached by Strohal et al. Furthermore, we have
recently analyzed the diversity of the TCR-β chains used by
T cells infiltrating nevi undergoing immune-mediated regression
(Musette et al, 1999). Two distinct populations of T cells
infiltrating the halo nevi can be distinguished: nonactivated or
polyclonally activated T cells, and highly restricted, clonally
expanded T cells. In addition, the T cells clonally expanded at
one site were repeatedly found in several halo nevi concomitently
analyzed in the same patient. Under the assumption that the
cells share the same rearranged TCR-α chain, the expanded
cells derive from the same α/β T cell clones and should thus
recognize the same molecular target(s), although the latter is
(are) located at different sites in the skin. Using a different
strategy, efficient antitumor responses in spontaneously regressing
melanomas have also been found to be oligoclonal (Ferradini
et al, 1993). Thus, it is tempting to suggest that expansion of
the same clones at distinct sites is a clue to the in vivo efficiency
of T cells in malignant diseases, whereas inefficient T cell
responses would be polyclonal or site-specific.
The ability to obtain a rapid characterization of the T cell
clones of a patient that are candidates for supporting a specific
antimelanocyte response is a key issue for the understanding of
the mechanisms that usually make specific T cells unable to
control cell progression. The faster candidate clones are defined
by PCR-based technologies, the faster their functional properties
can be ascertained and their specificity determined, whereas their
sorting out can be achieved using the proper MHC tetramers
loaded with specific peptides. We believe that coupling these
two approaches should allow the optimal monitoring of the
evolution of T cell expansions in melanomas and in solid tumors
in general.
